Poseida Therapeutics' Series B Round

Poseida Therapeutics raised a round of funding on April 03, 2018.

Poseida Therapeutics is translating gene editing technologies into lifesaving treatments. The company is developing CAR T-cell immunotherapies for multiple myeloma and other cancer types, as well as g…

Articles about Poseida Therapeutics' Series B Round: